It’s time to work out and work toward ovarian cancer cures! Follow along as certified Zumba instructor and OCRA supporter Samantha Schreiber leads you through a high-energy, fun, and impactful session, all to benefit ovarian cancer research. This class is part of our OCRA Heroes Boston series, a weekend of events to raise funds for … Continued
Some well-known people with deeply personal connections to ovarian cancer have echoed what we’ve been saying all September…this disease is a beast. And it doesn’t get talked about enough. Research for better treatments and a cure doesn’t get the funding it deserves. What we all deserve. Listen to what they have to say, and what draws them … Continued
An important victory for the ovarian cancer community came in 2006 when Congress passed Johanna’s Law. What is Johanna’s Law? Also known as The Gynecologic Cancer Education and Awareness Act, the legislation supports a variety of programs, research projects and activities at Centers for Disease Control and Prevention (CDC) aimed at educating healthcare providers and … Continued
In order to understand the complexities of how gene mutations affect an ovarian cancer diagnosis, OCRA-funded researcher Alexander Nikitin, MD, PhD and colleagues looked to see which ones drive, or possibly delay, the onset of the disease. “We found there were various genes that would help the process along, but interestingly, there were other genes … Continued
OCRA’s Uniting for Hope Virtual National Conference is September 29 – October 2 On Tuesday, September 29, we’re kicking off our virtual Ovarian Cancer National Conference, and time is running out to reserve your spot! Worried you can’t commit to four days in front of the computer? We understand. That’s why, for the first time, all of our sessions … Continued
With 1 in 78 diagnosed with ovarian cancer—and no early detection test for the disease—it is crucial that we spread the word so others can be knowledgeable about the symptoms and risk factors. We need YOUR help to share the facts this Ovarian Cancer Awareness Month! Below are graphics and sample language for you to … Continued
A new study found that patients who received heated intraperitoneal chemotherapy (HIPEC) after surgery lived almost 16 months longer than patients who were treated by surgery alone. Conducted with data from 584 patients with stage III epithelial ovarian cancer from multiple treatment centers, this study is the largest to date looking at the effects of … Continued
Ovarian Cancer Research Alliance (OCRA) is thrilled to announce a groundbreaking partnership with Microsoft’s AI for Health initiative. This unique collaboration will help OCRA accelerate ovarian cancer research by harnessing the power of data science and Artificial Intelligence (AI). With the support of Microsoft’s AI for Health initiative, a $60 million, five-year program, select OCRA grantees can utilize Microsoft’s … Continued
This September, Newk’s Cares, the ovarian cancer awareness movement founded by fast-casual restaurant Newk’s Eatery, will honor the legacy of late co-founder Lori Newcomb with a series of meaningful initiatives online and at all 100+ restaurant locations across the country. Newk’s Cares was founded after Lori was diagnosed with Stage IIIC ovarian cancer in 2013. Her vision and dedication has … Continued
For someone who has spent four decades blazing trails in ovarian cancer research and women’s healthcare, it might seem odd that the one word to sum up Dr. Jonathan Berek’s wide range of experiences and contributions would be ‘communication.’ But the conveying of information in empathetic, successful, understandable and compelling ways has been at the … Continued
“I’ve got to work on my elevator pitch.” Sarah Belzer is the president of Coconu, a personal care brand based in Salt Lake City, and she’ll be the first to laugh at the fact that she’s “in the lube business.” Sarah remembers going to a networking event with other women entrepreneurs and being incredibly nervous to … Continued
(August 6, 2020) Using medical records for 121 patients with gynecologic cancer and COVID-19, researchers were able to conduct an early look at the implications of a COVID-19 diagnosis on a patient with a gynecological cancer diagnosis. All of these patients were treated in the New York City area. Seventeen of the 121 patients (14.0%) … Continued
Get email updates about research news, action alerts, and ways to join the fight.
